spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  MedImmune 

 HSMN NewsFeed - 12 Sep 2024
Alchemab appoints Co-Founder Jane Osbourn as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Nov 2023
Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Oct 2022
Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data for Iomab-B
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Sep 2022
STORM Therapeutics Appoints Dr. Jerry McMahon as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Jun 2022
Anjarium Biosciences appoints Stephen Yoo, MD as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Nov 2021
INOVIO Expands Executive Leadership to Prepare for Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Nov 2021
NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jul 2021
Aeglea BioTherapeutics Appoints Jim Kastenmayer as General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jun 2021
Jim Vasselli, M.D., Joins Aulos Bioscience as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 May 2021
Soteria Biotherapeutics Launches with $42 Million Series A Financing Led by Roche Venture Fund and 5AM Ventures
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 15 Jun 2020
Aridis Pharmaceuticals Appoints Dr. Hasan Jafri as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 May 2020
Spirovant Sciences Appoints Roland Kolbeck, PhD, as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Oct 2019
Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jul 2019
Lilly's Verzenio(R) (abemaciclib) Significantly Extended Life in Women with HR+, HER2- Advanced Breast Cancer in MONARCH 2
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Dec 2018
Lilly Announces Publication of Analyses Showing Benefit of the Addition of Verzenio(R) (Abemaciclib) in Multiple Subgroups of Patients with Advanced Breast Cancer Identified as Having a More Concerning Prognosis
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Aug 2018
CBT Pharmaceuticals Announces New Leadership Structure to Drive Global Expansion
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 24 Apr 2018
Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Apr 2018
Compugen Announces Exclusive License Agreement With MedImmune for the Development of Bi-Specific and Multi-Specific Antibody Products
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 30 Oct 2017
Kymera Therapeutics Announces Series A to Advance Novel Therapeutic Modality and Develop Innovative Therapies
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 10 Jul 2017
FDA Grants Priority Review for Lilly's Abemaciclib for the Treatment of Advanced Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 May 2017
Cerecor Appoints Steven Boyd and Peter Greenleaf to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 8 May 2017
Regeneron and Inovio Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Combination Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Mar 2017
George Bickerstaff Elected to Inovio’s Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Mar 2017
Lilly Announces Phase 3 MONARCH 2 Breast Cancer Study of Abemaciclib Met Primary Endpoint of Progression-Free Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Dec 2016
Celldex Therapeutics Announces Appointment to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2016
Harpoon Therapeutics Appoints Gerald McMahon, Ph.D., as President and CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Dec 2016
Theresa LaVallee, Ph.D., Joins Celldex Therapeutics’ Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Nov 2016
Inovio’s Cancer Immunotherapy (INO-3112) Generates T Cell Immune Responses in Tumor Tissue and Peripheral Blood in Patients with HPV-Associated Head and Neck Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Oct 2016
Ardelyx Strengthens Executive Leadership with the Appointment of Reginald Seeto, MBBS, as Chief Operating Officer
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 12 Oct 2016
Inovio Expands Executive Team to Advance its DNA Immunotherapy Product Portfolio
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Oct 2016
Allergan plc Enters Into Licensing Agreement with AstraZeneca to Obtain Worldwide Rights to MEDI2070 Inflammatory Disorder Development Program
Biopharmaceuticals Gastroenterology Licensing
 HSMN NewsFeed - 4 Aug 2016
Inovio Pharmaceuticals Appoints Dr. Ami Shah Brown As Vice President Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jul 2016
AMAG Pharmaceuticals Appoints Mark Stanton as Vice President, Market Access & Corporate Accounts
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Apr 2016
Therabron Therapeutics Appoints Eric Richman as an Independent Board Member
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Mar 2016
Therabron Therapeutics Expands Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Feb 2016
Alder BioPharmaceuticals Strengthens and Expands Leadership Team Supporting Advancement of ALD403 Toward Future Commercialization
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Oct 2015
Vtesse, Inc. Expands Scientific Advisory Board and Appoints New VP of Clinical Operations to Support Late-Stage Clinical Study of Lead Drug Candidate VTS-270
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Oct 2015
Adheron Therapeutics to be acquired by Roche
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Oct 2015
Lilly Receives FDA Breakthrough Therapy Designation for Abemaciclib - a CDK 4 and 6 Inhibitor - in Advanced Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 Sep 2015
Molecular Response Appoints the Former Head of Translational Medicine Oncology at MedImmune/AstraZeneca, Brett Hall, Ph.D., as Chief Executive Officer
Diagnostics Personnel
 HSMN NewsFeed - 2 Sep 2015
ADC Therapeutics Secures $80m Financing to Progress Its Pipeline of Antibody Drug Conjugate Therapeutics in Oncology
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 10 Aug 2015
Inovio Pharmaceuticals Enters Into Strategic Cancer Vaccine Collaboration and License Agreement With MedImmune
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 Aug 2015
Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Jul 2015
Immunocore Secures $320 Million (£205 Million) in Europe's Largest Private Life Sciences Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 6 Feb 2015
Catabasis Names Rick Modi Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Dec 2014
Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology
Biopharmaceuticlas Oncology Personnel
 HSMN NewsFeed - 18 Sep 2014
Evotec Takes Legal Steps Against Andromeda Biotech, Ltd.
Biopharmaceuticals Litigation
 HSMN NewsFeed - 7 Aug 2014
Specialty Vaccine Company PaxVax Expands Global Commercial Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jun 2014
ARIAD Announces Three Key Appointments to Its Global Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jun 2014
Immune Appoints Gad Berdugo to Board of Directors and Karin Hehenberger, M.D., Ph.D to Senior Vice President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 May 2014
Immune Pharmaceuticals Announces Phase 3 Development and Commercialization Strategy for AMIKET
Biopharmaceuticals
 HSMN NewsFeed - 14 Apr 2014
Kite Pharma Expands Leadership Team and Announces Senior Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Apr 2014
Immune CEO Announces New Operational Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Mar 2014
Baxter Announces Plans to Create Two Separate Leading Global Healthcare Companies
Biopharmaceuticals Devices Personnel
 HSMN NewsFeed - 12 Feb 2014
Osiris Therapeutics Promotes Frank Czworka to Vice President and General Manager of Wound Care
Devices Regenerative Medicine Wound Care Personnel
 HSMN NewsFeed - 27 Jan 2014
Synthetic Biologics Strengthens Clinical & Regulatory Team to Support Expanding Pipeline of Infectious Disease Programs
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 13 Jan 2014
CorMedix Expands Neutrolin(R) Sales with Middle East Distribution Agreements
Biopharmaceuticals Devices Distribution
 HSMN NewsFeed - 7 Jan 2014
Dr. Seth Rudnick Joins G1 Therapeutics as Executive Chairman
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Nov 2013
Catabasis Closes $32.4 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Oct 2013
G1 Therapeutics Raises $12.5M Series A Financing Led by MedImmune Ventures
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 6 Sep 2013
Vital Therapies, Inc. Expands Executive Team
Devices Regenerative Medicine Personnel
 HSMN NewsFeed - 20 Aug 2013
EpiCept Announces Reverse Stock Split and Change of Corporate Name to Immune Pharmaceuticals Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Jul 2013
Sialix Raises $1.0 Million in Second Round of Series B Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 24 Jun 2013
AMAG Pharmaceuticals Appoints Steven Caffe, M.D. as Chief Development and Regulatory Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jun 2013
NGM Biopharmaceuticals and MedImmune, AstraZeneca's Biologics Arm, Announce Agreement to Discover and Develop Therapies for Diabetes and Obesity
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 10 Jun 2013
Histogenics Announces Peter Greenleaf as CEO
Regenerative Medicine Personnel
 HSMN NewsFeed - 10 Apr 2013
Novavax Appoints Amy B. Fix Vice President of Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Feb 2013
EpiCept Corporation and Immune Pharmaceuticals Amend Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Jan 2013
Inotek Pharmaceuticals Appoints David R. King as Executive Chairman
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 19 Nov 2012
AGTC Secures $37.5M Series B Funding
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 8 Nov 2012
Immune Pharmaceuticals and EpiCept Corporation Agree to Merge
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Oct 2012
Sigma-Tau Pharmaceuticals, Inc. Announces Appointment of New Vice President of Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Oct 2012
Dr Roger M. Perlmutter Joins Heptares' Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jul 2012
NuPathe Appoints Armando Anido as Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 16 Jul 2012
Coferon, Inc. Announces $12 Million Series B Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 16 May 2012
Armando Anido Joins Respira Therapeutics, Inc. Board of Directors
Devices Drug Delivery Personnel
 HSMN NewsFeed - 3 May 2012
Creabilis Appoints Dr Simon Russell as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Apr 2012
Kolltan Pharmaceuticals Appoints Gerald McMahon, Ph.D., President & Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Mar 2012
Heptares Grants Shire an Exclusive Worldwide Licence to Develop and Commercialise Novel Drug Candidate for CNS Disorders
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 26 Jan 2012
Amgen to Acquire Micromet
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 4 Jan 2012
NexImmune Appoints Kenneth Carter, PhD, as President and CEO and Jonathan Schneck, MD, PhD as Chairman of Clinical and Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Dec 2011
Catabasis Pharmaceuticals Announces $8 Million Series A Extension Financing
Biopharmaceuticalas Venture Capital
 HSMN NewsFeed - 5 Dec 2011
Micromet Appoints Joseph Lobacki Senior Vice President and Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Nov 2011
CorMedix Appoints Pharmaceutical Veteran, Matthew Duffy to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Sep 2011
IMMUNE Pharmaceuticals Announces Alan G. Harris MD, PhD, FRCP as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Sep 2011
Immunovaccine Announces Appointment of John Trizzino as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jun 2011
Novavax Appoints Dr. Timothy Hahn Senior Vice President of Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jun 2011
Arno Therapeutics Names Alexander Zukiwski, M.D., Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jun 2011
Genocea Biosciences Hires Ravi Venkataramani, Ph.D. as Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jun 2011
Micromet Appoints Ulrich Grau, Ph.D. Executive Vice President and Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Jun 2011
Tetragenetics Announces New CEO and Expands Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 May 2011
FDA Approves Trial of Pathway Therapeutics, Inc. Cancer Drug; $7.5 Million Financing in Place to Advance Novel PI3K/mTOR Inhibitor Portfolio
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 May 2011
Resolve Announces Series A Financing, New Board Members
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 19 Apr 2011
Novavax Announces Change in Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Mar 2011
Omthera Pharmaceuticals Raises $33.9 Million in Series B Funding Led by New Enterprise Associates
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Jan 2011
MedImmune In-Licenses Clinical-Stage Anti-Inflammatory Monoclonal Antibody From Amgen
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 Dec 2010
NovaDigm Therapeutics Appoints C. Boyd Clarke to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2010
Pulmatrix Names Eva Jack as Chief Business Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 8 Dec 2010
Catabasis Pharmaceuticals Secures $14.5 Million Second Tranche in Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Nov 2010
Vanda Pharmaceuticals Appoints Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Oct 2010
Jennerex Names Dr. Mark P. Backer as Senior Vice President of Technical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Sep 2010
Seattle Genetics Announces Phase IIb Trial of Lintuzumab (SGN-33) in Patients with Acute Myeloid Leukemia (AML) Did Not Meet Primary Endpoint
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Jul 2010
K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2010
Trubion Pharmaceuticals Wins Genentech and Biogen Idec Patent Appeal
Biopharmaceuticals Litigation
 HSMN NewsFeed - 3 Jun 2010
3-V Biosciences Appoints Edward M. Connor, Jr., MD, Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 May 2010
Seattle Genetics Names Vice President, Sales and Announces Management Promotion
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 May 2010
PharmAthene Appoints Eric I. Richman as Interim Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Mar 2010
PharmAthene Appoints Eric I. Richman as President and Chief Operating Officer and Announces Senior Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Mar 2010
Auxilium Announces Promotion of Benjamin Del Tito Jr., Ph.D. to Executive Vice President, Regulatory Affairs and Project Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Mar 2010
Catalyst Biosciences Appoints William J. Dawson Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Feb 2010
Xencor Appoints Edgardo Baracchini, Ph.D., to Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jan 2010
Adolor Corporation Announces Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jan 2010
VentiRx Pharmaceuticals Raises $25 Million in Series A Extension Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Dec 2009
Seattle Genetics and Millennium: The Takeda Oncology Company Announce Strategic Collaboration for Novel Late-Stage Lymphoma Program Brentuximab Vedotin (SGN-35)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Dec 2009
Epizyme Closes $40M Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Oct 2009
Seattle Genetics Names Head of Commercial and Announces Management Promotion
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Oct 2009
Arginetix Closes $10.75 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Sep 2009
Micromet Appoints Former Roche Oncology Clinical Leader Jan Fagerberg as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Sep 2009
Rib-X Pharmaceuticals, Inc. Appoints Tony Zook of MedImmune to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jul 2009
Novavax Announces Appointment of John J. Trizzino as Senior Vice President, International and Government Alliances
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 May 2009
Altair Therapeutics Appoints Dr. Joel Martin President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 May 2009
VaxInnate Corporation Closes $30 Million Round of Financing; Wellcome Trust Leads Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Mar 2009
Seattle Genetics Receives FDA Fast Track Designation for SGN-35 for the Treatment of Hodgkin Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Feb 2009
Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jan 2009
Hydra Biosciences Raises $22 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Jan 2009
MedImmune Submits Marketing Authorisation Application in European Union for Intranasal Vaccine to Prevent Seasonal Influenza
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Nov 2008
AstraZeneca Appoints Rich Fante as President of its U.S. Business
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Nov 2008
MedImmune Announces Zook as President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Sep 2008
Seattle Genetics Adds to Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2008
MAP Pharmaceuticals Appoints Alan H. Cohen, M.D., as Vice President, Clinical Development and Medical Affairs, Pulmonary
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2008
Rib-X Pharmaceuticals, Inc. Appoints Dr. Joseph Amprey of MedImmune Ventures to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jul 2008
Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Jun 2008
Genaera Corporation Elects Paul K. Wotton to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 May 2008
MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Mar 2008
Micromet Establishes New Scientific Advisory Board for Its BiTE Antibody Technology with Leading Experts in the Fields of Oncology, Immunotherapy and Drug Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Mar 2008
LigoCyte Pharmaceuticals Finalizes Agreement for $28M Series 'C' Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Mar 2008
Avalon Pharmaceuticals Appoints Philip Frost, M.D., Ph.D., to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Mar 2008
Elusys Therapeutics Appoints Robert Gundel as Vice President of Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Mar 2008
BrainCells Inc. Completes $30 Million Initial Closing of Series B Financing
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 7 Feb 2008
MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2008
MedImmune Submits Biologics License Application to FDA for Motavizumab
Biopharmaceuticals
 HSMN NewsFeed - 4 Feb 2008
Infinity and MedImmune Announce Approval for Generic Name for Novel Hsp90 Inhibitor
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Jan 2008
Alfacell Appoints David Sidransky Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2008
MedImmune Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas
Venture Capital
 HSMN NewsFeed - 20 Dec 2007
MedImmune Expands Scientific and Engineering Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2007
Micromet Announces Changes in Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Nov 2007
Lev Pharmaceuticals Expands Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Nov 2007
Ambit Biosciences Raises Over $49 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Nov 2007
MedImmune Announces Seven Key Promotions and New Hires
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Oct 2007
David Mott Appointed Non Executive Director at Shire
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Oct 2007
AVI BioPharma Announces Changes to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Oct 2007
AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
Biopharmaceuticals
 HSMN NewsFeed - 25 Oct 2007
Xencor Expands Series E Financing to $60 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Oct 2007
Jeffrey D. Bloss, M.D., Joins Xencor as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Oct 2007
Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Oct 2007
Metastatix Closes $35 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Oct 2007
Genaera Corporation Announces Licensing of Exclusive Rights to Pexiganan, a Novel Anti-Infective Drug Candidate, by Macrochem Corporation
Biopharmaceuticals Licensing
 HSMN NewsFeed - 27 Sep 2007
Critical Therapeutics and Dey Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets
Biopharmaceuticals
 HSMN NewsFeed - 25 Sep 2007
Critical Therapeutics Highlights Near-Term Milestones to Drive Commercial Success and Clinical Development
Biopharmaceuticals
 HSMN NewsFeed - 25 Sep 2007
Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Sep 2007
MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 Sep 2007
FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Sep 2007
Infinity and MedImmune Receive Orphan Drug Designation for IPI-504 for Treatment of Gastroinstestinal Stromal Tumors
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Sep 2007
Micromet Appoints Mark Reisenauer as Senior Vice President and Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Aug 2007
Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Aug 2007
Inotek Pharmaceuticals Secures $19 million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Aug 2007
Critical Therapeutics Appoints Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Aug 2007
Vical Names Andrew de Guttadauro Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Aug 2007
Avalon Pharmaceuticals Appoints Bradley G. Lorimier Chairman of Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jul 2007
Elusys Appoints New Chairman of the Board and a Vice President of Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jul 2007
Micromet Promotes Carsten Reinhardt to Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jun 2007
New Study in Journal of Pediatrics Suggests Synagis(R) (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
Biopharmaceuticals
 HSMN NewsFeed - 28 Jun 2007
Critical Therapeutics and Dey, L.P. Complete Definitive Co-Promotion Agreement for Perforomist(TM) Inhalation Solution
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 26 Jun 2007
Lev Pharmaceuticals, Inc. Announces Completion of Marketing and Sales Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jun 2007
Critical Therapeutics' Zileuton Provides Additional Asthma Control When Combined with Inhaled Corticosteroids
Biopharmaceuticals
 HSMN NewsFeed - 21 Jun 2007
Elusys Names Jeremy D. Middleton Vice President of Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jun 2007
Seattle Genetics Adds Industry Veterans John P. McLaughlin and Daniel G. Welch to its Board of Directors and Promotes Eric Dobmeier to Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Jun 2007
Critical Therapeutics Announces the Publication of Data for ZYFLO CR(TM) (Zileuton) Extended-Release Tablets in the Journal of Asthma
Biopharmaceuticals
 HSMN NewsFeed - 6 Jun 2007
Two Significant Hires Round-Out VaxInnate's Core Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2007
Final Data from a Phase 2 Trial Presented at ASCO Specifies Dose-dependent Activity of Adecatumumab (MT201)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2007
FDA Approves Critical Therapeutics' Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for Asthma
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 May 2007
FDA Advisory Committee Recommends Expanded Use of FluMist(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 May 2007
MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
Biopharmaceuticals
 HSMN NewsFeed - 3 May 2007
Avalon Pharmaceuticals, Inc. Names C. Eric Winzer New Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 May 2007
Critical Therapeutics' Co-Promotion Partner, DEY, L.P., Launches U.S. Sales and Marketing of ZYFLO(R) for Asthma
Biopharmaceuticals
 HSMN NewsFeed - 24 Apr 2007
Astrazeneca to Acquire Medimmune for $58 Per Share in a Fully Recommended, All-Cash Transaction with a Total Enterprise Value of $15.2 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Apr 2007
Advancis Pharmaceutical Appoints New Board Member
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Apr 2007
MedImmune Explores Strategic Alternatives
Biopharmaceuticals
 HSMN NewsFeed - 2 Apr 2007
MedImmune Announces Addition of Robert H. Hotz To Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Mar 2007
Seattle Genetics Announces Extension of Antibody-Drug Conjugate Collaboration with Genentech
Biopharmaceuticals
 HSMN NewsFeed - 20 Mar 2007
Seattle Genetics Appoints Dr. Tom Reynolds Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Mar 2007
Micromet and TRACON Pharmaceuticals Sign Exclusive Worldwide License Agreement to Develop and Commercialize D93, a Humanized Antibody for Cancer Treatment
Biopharmaceuticals Licensing
 HSMN NewsFeed - 14 Mar 2007
Critical Therapeutics and DEY, L.P. Enter into Co-Promotion Agreement for Respiratory Care Products
Biopharmaceuticals
 HSMN NewsFeed - 6 Mar 2007
Oncologic Appoints Stephen T. Isaacs as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Mar 2007
Vidacare Announces Director of Sales Operations, Bart P. Jones
Devices Personnel
 HSMN NewsFeed - 26 Feb 2007
Artisan Pharma, Inc. Hires Senior Clinical and Regulatory Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Feb 2007
ARYx Therapeutics Appoints New Chief Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Feb 2007
MedImmune Further Expands its Commercial Organization Expertise With Appointment of Two Additional Vice Presidents
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Feb 2007
Inspire Announces Executive Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Feb 2007
Seattle Genetics Receives Orphan Drug Designations for its SGN-33 and SGN-35 Programs
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Feb 2007
Morphotek Obtains Exclusive License from Micromet for Antibody to Treat Melanoma and Other Cancers
Biopharmaceuticals Licensing
 HSMN NewsFeed - 1 Feb 2007
Xencor Appoints Jade R. Brown as Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Feb 2007
AstraZeneca Acquires Arrow Therapeutics To Broaden Anti-Infective Capabilities
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Jan 2007
MedImmune Announces District Court's Rejection of Sun Pharmaceutical's Motion to End Litigation Regarding Generic Amifostine
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 8 Jan 2007
Sequoia Pharmaceuticals Raises $35 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Jan 2007
FDA Approves MedImmune's Refrigerated Formulation of FluMist(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Jan 2007
Genentech and Seattle Genetics Announce Exclusive Global Licensing Agreement for Development and Commercialization of SGN-40
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 8 Jan 2007
Seattle Genetics and Agensys Announce Collaboration to Co-Develop and Commercialize Antibody-Drug Conjugate Therapies for Cancer
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 Jan 2007
Elusys Announces Collaborative Research and License Agreement with Pfizer
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 Jan 2007
Avalon Pharmaceuticals Names Clinical Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Dec 2006
Critical Therapeutics' Board of Directors Appoints Frank Thomas as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Dec 2006
ZLB Behring Completes Purchase of CytoGam(R) Immunoglobulin Therapy From MedImmune
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 15 Dec 2006
Critical Therapeutics Announces NIH-Sponsored Study to Investigate the Efficacy Of ZYFLO(R) In Patients with Acute Exacerbations Of COPD
Biopharmaceuticals
 HSMN NewsFeed - 5 Dec 2006
Ambit Biosciences Appoints Kerry Kelly, J.D., as Vice President and General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Dec 2006
Micromet, Inc. and Serono Amend Collaboration Agreement and Continue Development of Adecatumumab (MT201)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Nov 2006
Biota and Boehringer Ingelheim Complete US$102 Million License for HCV Program
Biopharmaceuticals Licensing
 HSMN NewsFeed - 15 Nov 2006
Critical Therapeutics Announces Efficacy Data for Controlled-Release Formulation of Zileuton Presented at ACAAI 2006 Annual Meeting
Biopharmaceuticals
 HSMN NewsFeed - 6 Nov 2006
Numax(R) Achieves Primary Endpoint In Preliminary Analysis of Data From Comparative Phase 3 Trial With Synagis(R)
Biopharmaceuticals
 HSMN NewsFeed - 31 Oct 2006
Prominent Oncologist, Dr. David Sidransky, Joins Zila Board
Diagnostics Personnel
 HSMN NewsFeed - 27 Oct 2006
Critical Therapeutics Outlines New Business Strategy Focusing on Controlled-Release and Intravenous Formulations of Zileuton
Biopharmaceuticals
 HSMN NewsFeed - 17 Oct 2006
Critical Therapeutics Announces Acceptance of Controlled-Release Zileuton New Drug Application for Review by FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Oct 2006
Micromet, Inc. Expands Management and Appoints Christopher P. Schnittker as Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Oct 2006
Final Data From Two Phase II Trials Indicate Activity of Adecatumumab (MT201) in Breast and Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Sep 2006
Cerus Strengthens European Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2006
Panacea Pharmaceuticals Announces Appointments of Christine L. Brauer, Ph.D. as Vice President, Regulatory Affairs; and Jefferey Jones, M.S., as Director of Quality
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Sep 2006
MaxCyte Strengthens Leadership Team
Regenerative Medicine Personnel
 HSMN NewsFeed - 7 Sep 2006
Metastatix Completes Series a Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Jul 2006
MedImmune Receives Complete Response Letter From FDA for New Formulation of FluMist(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Jul 2006
Critical Therapeutics Announces Change in Leadership of Specialty Sales Force
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jul 2006
Elusys Therapeutics Completes $23 Million Series D Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Jul 2006
MedImmune Receives FDA Approval to Use Reverse Genetics Technology for FluMist(R) Vaccine Production
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Jun 2006
Auxilium Appoints Armando Anido as Chief Executive Officer and President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jun 2006
Critical Therapeutics Announces Changes to Management Team and Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 May 2006
MedImmune Fills Senior Marketing and Sales Post
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 May 2006
Seattle Genetics Names Pamela Trail, Ph.D., as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 May 2006
YM Biosciences completes acquisition of Eximias
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 5 May 2006
Micromet and CancerVax Complete Merger To Form Micromet, Inc.
Biopharmaceuticals Mergers & Acquisitions
Return to NewsFeed  

 Additional items found! 122

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 122 additional stories matching:
MedImmune
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.